Delivery Order SPE2DR25D1104-SPE2DR26FL248
Award Date 2/17/26
Potential Completion Date 3/10/26
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $2,369.20 delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for pharmaceutical supply XDEMVY 0.25% DROP 10ML. The order is issued under the DLA Troop Support Medical IDC, a $999,999,999 indefinite delivery contract running through December 2026 that enables supply of pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order has a firm fixed price, an...
- The Defense Logistics Agency issued a $3,553.80 delivery order to Amerisourcebergen Drug Corp on February 11, 2026, for pharmaceutical supply (XDEMVY 0.25% DROP 10ML). The order is issued under the company's Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2026, which supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken, PA. The order has a firm...
- The Defense Logistics Agency issued a $1,184.60 delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for pharmaceutical supply (4570779101 XDEMVY 0.25% DROP 10ML) with a firm fixed price and no set-aside. Place of performance is Conshohocken, PA. The order is due for completion on March 3, 2026. Amerisourcebergen Drug Corp operates under a parent indefinite delivery contract with DLA Troop Support Medical valued at $999,999,999.00 and running through December 2026, supporting...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 2, 2026, with a ceiling value of $2,369.20 for pharmaceutical supply (XDEMVY 0.25% DROP 10ML). Place of performance is Conshohocken, PA. The order is due for ultimate completion February 24, 2026. Pricing is firm fixed price under a no-set-aside competitive award. The delivery order is issued against Amerisourcebergen Drug Corp's parent IDC with DLA Troop Support Medical, a $999,999,999 global...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 27, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical product with a ceiling value of $1,223.59. This firm fixed price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, was competitively awarded with no set-aside designation. The place of performance...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp for XDEMVY 0.25% DROP 10ML, a pharmaceutical product. This competitively awarded contract, issued on October 27, 2025, with an ultimate completion date of November 18, 2025, utilizes firm fixed-price pricing and requires performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, a pharmaceutical product for federal medical procurement. This firm fixed-price delivery order, issued on December 30, 2025, is scheduled for completion by January 22, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively awarded through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical products, with a ceiling value of $1,184.60 under a firm fixed price contract. The delivery order, classified as a child contract, is set to be completed by January 7, 2026, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award represents a competitive procurement...
- On January 14, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp for XDEMVY 0.25% DROP 10ML, a pharmaceutical product to be delivered to Conshohocken, Pennsylvania by February 5, 2026. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,184.60 for XDEMVY 0.25% Drop 10ML pharmaceutical products. This is a firm fixed-price delivery order with an ultimate completion date of January 21, 2026, and represents a competitively awarded, non-set-aside contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FL248Delivery Order
The Defense Logistics Agency issued a $1,184.60 delivery order to Amerisourcebergen Drug Corp on February 17, 2026, for pharmaceutical supply (XDEMVY 0.25% DROP 10ML) with a firm fixed price. Place of performance is Conshohocken, PA. The order is due by March 10, 2026. The source does not identify the parent IDV by name; however, Amerisourcebergen Drug Corp operates under a DLA Troop Support Medical IDC valued at $999,999,999.00 through December 2026 as its primary pharmaceutical supply vehicle for military healthcare programs globally.
Generated 5/18/26, 9:50 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 2/16/26 |